Pharmaceutical Benefits Advisory Committee
Glossary of Q Terms
Glossary to accompany the November 1995 edition of the Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee
Glossary of Terms
Glossary of Terms to accompany the 1995 edition of the Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee
>> References
>> Glossary of terms - A
>> Glossary of terms - B
>> Glossary of terms - C
>> Glossary of terms - D
>> Glossary of terms - E
>> Glossary of terms - F
>> Glossary of terms - H
>> Glossary of terms - I & L
>> Glossary of terms - M
>> Glossary of terms - N
>> Glossary of terms - O
>> Glossary of terms - P
>> Glossary of terms - Q
>> Glossary of terms - R
>> Glossary of terms - S
>> Glossary of terms - T
>> Glossary of terms - U, V & W
Glossary of Terms to accompany the 1995 edition of the Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee
>> References
>> Glossary of terms - A
>> Glossary of terms - B
>> Glossary of terms - C
>> Glossary of terms - D
>> Glossary of terms - E
>> Glossary of terms - F
>> Glossary of terms - H
>> Glossary of terms - I & L
>> Glossary of terms - M
>> Glossary of terms - N
>> Glossary of terms - O
>> Glossary of terms - P
>> Glossary of terms - Q
>> Glossary of terms - R
>> Glossary of terms - S
>> Glossary of terms - T
>> Glossary of terms - U, V & W
- Q-TWiST quality-adjusted time without symptoms and toxicity
- QALY quality-adjusted life-year
- Quality of life (see also health status) The extent to which an individual perceives himself or herself able to function physically, psychologically and socially.
- Quality-adjusted life-year (see also healthy-year equivalent) The number of years of life weighted by a utility value of the relative quality of life experienced.
- Quality-adjusted time without symptoms and toxicity A method of estimating quality-adjusted life-years (developed originally in cancer research) which divides life expectancy into: time with toxicity from chemotherapy; followed by time free of symptoms of disease or chemotherapy toxicity; followed by time with disease symptoms. Each of these time periods is adjusted by the respective utility weight.
- Quasi-experimental study (see Appendix N) A non-randomised study in which the investigator lacks full control over the allocation and/or the timing of the therapy, but otherwise conducts the study as a randomised trial. An umbrella term for "before and after" studies, case series with historical controls and comparison of the results of single-arm studies.
